You are here: Industry Insights > DRL

News List

DRL’s Visakhapatnam unit gets six observations by German regulator expressbpd
September 11, 2017
The facility’s compliance with the CAPA and other applicable regulations will be reviewed again by the regulator by November 2018 for continuation of EU-GMP certification
DRL launches Bupropion Hydrochloride and Metaxalone tabs expressbpd
September 07, 2017
DRL’s Bupropion Hydrochloride Extended-Release tablets, USP (XL), 150 mg and 300 mg, are each available in bottle count sizes of 30, 90 and 500.
DRL announces the launch of Cefixime in the US expressbpd
August 29, 2017
It is a therapeutic equivalent generic version of Suprax
Repeated regulatory reprimands will erode investor confidence in DRL: Analysts expressbpd
August 15, 2017
German regulator’s observations on GMP violations include systemic data integrity issues
DRL commercialises Vozet tabs in India expressbpd
July 19, 2017
Vozet tabs are indicated for the treatment of allergic Rhinitis and chronic Urticaria
DRL launches of Progesterone Capsules in the US Market financialexpress
April 25, 2017
Progesterone Capsules, 100 mg and 200 mg, are available in bottle count size of 100
DRL in agreement with Integra LifeSciences expressbpd
March 28, 2017
To market and distribute DuraGen Plus and Suturable DuraGen Dural Regeneration in India, Dr Reddy’s Laboratories (DRL) and Integra LifeSciences Holdings Corporation have entered into an exclusive distribution agreement.

Previous page 1 2 Next page